Citation Impact
Citing Papers
Poverty Impedes Cognitive Function
2013 StandoutScience
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Mammalian Clock Gene Cryptochrome Regulates Arthritis via Proinflammatory Cytokine TNF-α
2009
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Can categorization of patient background problems be used to determine early termination in a clinical trial?
1988
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The metabolic syndrome
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Clinical Pharmacokinetics in Organ Transplant Patients
1989
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
1996
Racial Differences in Drug Response
1989
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
A Strategy for O-Glycoproteomics of Enveloped Viruses—the O-Glycoproteome of Herpes Simplex Virus Type 1
2015
Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial
2002
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The metabolic syndrome
2005 Standout
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
The Antiphospholipid Syndrome
2002 Standout
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
2018
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
The effect of chronic renal failure on drug metabolism and transport
2008
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Alzheimer's Disease
2010 Standout
Rheumatoid arthritis
2010 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker
1998
Infection in Organ-Transplant Recipients
1998 Standout
Inappropriate Medications for Elderly Patients
2004
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Anemia of Chronic Disease
2005 Standout
Adherence to Medication
2005 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs
1987
A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus
1979
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Dosing Adjustment of 10 Antimicrobials for Patients with Renal Impairment
1995
How Often Is Medication Taken as Prescribed?
1989 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
The 1982 revised criteria for the classification of systemic lupus erythematosus
1982 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Systemic lupus erythematosus
2007
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Platelet Function and Coagulation Profile in Lupus Erythematosus
1974
Preparation and anticancer activity of two tryptamine derived platinum complexes
1991
Factors Related to Errors in Medication Prescribing
1997 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Thomas Gibson being referenced
Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999-2010
2013
Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl
1996
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.
1992
Elimination of procainamide in end stage renal failure
1975
Pharmacokinetics of oral propranolol in chronic renal disease
1974
Hemoperfusion for methotrexate removal
1978
Nervous system involvement in systemic lupus erythematosus
1976
Cefsulodin kinetics in renal impairment
1982
Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients*
1980
Kinetics of procainamide and N-acetylprocainamide in renal failure
1977
Imipenem/cilastatin: Pharmacokinetic profile in renal insufficiency
1985
Plasma Protein Binding of d‐Propoxyphene in Normal Subjects and Anephric Patients
1978
Subclinical liver disease in systemic lupus erythematosus.
1982
Propranolol in hypertensive dialysis patients: Efficacy and compliance
1975
Renal Disease and Drug Metabolism: An Overview
1986
Use of the American Rheumatism Association's Preliminary Criteria for the Classification of Systemic Lupus Erythematosus
1972
Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient
1980
N‐Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis
1979
Effect of dose and uremia on plasma and urine profiles of propranolol metabolites
1980